CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
Low-level laser therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06136975
NCT06136975N/ACompleted
CompareCT.gov

The Efficacy of Low-level Laser Therapy in Relieving Vaginal Dryness and Lower Urinary Tract Symptoms

National Taiwan University Hospital·observational·Posted Nov 18, 2023·Updated Nov 18, 2023

In Brief

An observational study evaluating Low-level laser therapy for Vaginal Atrophy and Urinary Incontinence,Stress. Completed, enrolled 41 participants across 1 site.

Detailed Summary

Genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) are common for women. Low-level laser therapy (LLLT) was applied for wound healing, but there was no study regarding treatment effect of GSM and SUI. This retrospective study aims to assess the efficacy of LLLT in alleviating GSM and SUI.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVaginal Atrophy, Urinary Incontinence,Stress
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedNov 18, 2023
Enrollment StartSep 30, 2022
Primary CompletionAug 14, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.6 years ago

Interventions

Low-level laser therapydevice

The treatment was once a week for eight weeks. The patient was in a supine position. The gain medium of the laser was Gallium-Aluminum-Arsenide. The laser was introduced into vagina via a silicon vaginal probe inserted by a doctor for 30 minutes (wavelength 660nm, power density 18.17mW/cm2, energy density 0.018J/cm2s, total energy density 32.4J/cm2).